![Tyler Jacks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 11 M $ in data 31/05/2026
Tyler E.
Jacks is the founder of T2 Biosystems, Inc., founded in 2006, and Dragonfly Therapeutics, Inc., founded in 2016.
Current jobs include Independent Director at Amgen, Inc. since 2012, Independent Director at Thermo Fisher Scientific, Inc. since 2009, President & Director at Commonwealth Cancer Consortium, Inc. since 2021, and Professor at Massachusetts Institute of Technology since 2007.
Former jobs include Chairman at National Cancer Institute and Director at David H.
Koch Institute for Integrative Cancer Research from 2007 to 2021.
Education history includes an undergraduate degree from Harvard University in 1983 and a doctorate from The University of California, San Francisco in 1988.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/05/2026 | 18.284 ( 0% ) | 6 M $ | 31/05/2026 | |
| 20/05/2026 | 9.462 ( 0% ) | 5 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Direttore/Membro del Consiglio | 26/05/2009 |
| AMGEN INC. | Direttore/Membro del Consiglio | 01/01/2012 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
Commonwealth Cancer Consortium, Inc.
 Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | Presidente | 01/02/2021 |
| Società | Posizione | Fine |
|---|---|---|
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Direttore/Membro del Consiglio | 01/01/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Presidente | 01/01/2016 |
| T2 BIOSYSTEMS, INC. | Fondatore | 01/01/2013 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Health Technology |
Commonwealth Cancer Consortium, Inc.
Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
